Histopathologic outcomes of hepatocellular carcinoma treated with transarterial radioembolization with yttrium-90 resin microspheres
European Journal of Nuclear Medicine and Molecular Imaging · 2026-01 · 53 (2) · 876-889
DOI: 10.1007/s00259-025-07471-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 05.08.2025. Verfasst von Ammar Sarwar und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Interventional Radiology, Department of Radiology, Beth Israel Deaconess Medical Center, 1 Deaconess Road Rosenberg 3, Boston, MA, 02215,…. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Yttrium Radioisotopes, Liver Neoplasms, Microspheres. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 36 Literaturangaben.
Abstract (Originalsprache)
PURPOSE: To evaluate the pathologic outcomes of 90Y-TARE of HCC with resin microspheres prescribed using the single-compartment model and to correlate posttreatment dose with outcomes. METHODS: This retrospective single-center study included adult patients with HCC who underwent 90Y-TARE with resin microspheres before liver transplantation or surgery. Histopathologic evaluation of liver tissue was performed. Complete pathologic necrosis (CPN) was defined as 100% tumor necrosis, extensive necrosis as 50-99%, and partial necrosis as < 50%. Posttreatment voxel-based dosimetry was conducted. Additional subgroup analysis was done to compare tumors with complete and incomplete necrosis. RESULTS: Among 28 patients (median age, 64 years [IQR, 57-69 years]); 86% males,75% BCLC 0-A) with 37 HCC tumors, complete, extensive and partial pathologic necrosis were achieved in 27/37(73%), 8/37(22%) and 2/37(5%) tumors, respectively. Tumors with CPN were significantly smaller than those without CPN (2.2 vs. 3.4 cm, P = 0.03), with longer interval between the 90Y-TARE and liver surgery (274 vs. 143 days, P = 0.048). All tumors with a mean tumor absorbed dose ≥ 433 Gy had CPN. Conversely, all tumors in which 4% or more of the tumor volume received a dose less than 100 Gy had incomplete necrosis. ROC analysis identified D95 ≥ 133 Gy (AUC 0.96 [95%CI: 0.9-1]) and V0-100 (%) < 5% (AUC 0.9 [95%CI: 0.75-0.97]) as predictors of CPN with 100% and 78% specificity, respectively. CONCLUSION: Among HCC patients who underwent 90Y-TARE with resin microspheres, 73% achieved complete pathologic necrosis. All tumors with a mean tumor absorbed dose ≥ 433 Gy achieved CPN. CLINICAL TRIAL NUMBER: not applicable.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Interventional Radiology, Department of Radiology, Beth Israel Deaconess Medical Center, 1 Deaconess Road Rosenberg 3, Boston, MA, 02215, USA. asarwar@bidmc.harvard.edu.
- Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
- Division of Interventional Radiology, Department of Radiology, Beth Israel Deaconess Medical Center, 1 Deaconess Road Rosenberg 3, Boston, MA, 02215, USA.
- Department of Radiology, Beth Israel Deaconess Medical Center, Boston, MA, USA.
- Division of Hepatology and Gastroenterology, Department of Internal Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.
- Division of Hematology and Medical Oncology, Department of Internal Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USA.
ORCID-Profile: Ammar Sarwar
Zitieren
APA
Sarwar, A., Nasser, I., Weinstein, J. L., Odeh, M., Babar, H., Dinh, D., Curry, M., Bullock, A., Eckhoff, D., Dib, M., Parker, J. A., & Ahmed, M. (2026). Histopathologic outcomes of hepatocellular carcinoma treated with transarterial radioembolization with yttrium-90 resin microspheres. European Journal of Nuclear Medicine and Molecular Imaging, 53(2), 876-889. https://doi.org/10.1007/s00259-025-07471-0
Vancouver
Sarwar A, Nasser I, Weinstein JL, Odeh M, Babar H, Dinh D, et al. Histopathologic outcomes of hepatocellular carcinoma treated with transarterial radioembolization with yttrium-90 resin microspheres. European Journal of Nuclear Medicine and Molecular Imaging. 2026;53(2):876-889. doi:10.1007/s00259-025-07471-0
BibTeX
@article{Sarwar2026,
author = {Sarwar, Ammar and Nasser, Imad and Weinstein, Jeffrey L and Odeh, Mahmoud and Babar, Hafsa and Dinh, Diana and Curry, Michael and Bullock, Andrea and Eckhoff, Devin and Dib, Martin and Parker, John A and Ahmed, Muneeb},
title = {Histopathologic outcomes of hepatocellular carcinoma treated with transarterial radioembolization with yttrium-90 resin microspheres},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2026},
volume = {53},
number = {2},
pages = {876--889},
doi = {10.1007/s00259-025-07471-0}
}
EUVIMED